Bellevue Group’s Clovis Oncology, Inc. CLVS Stock Holding History

Bellevue Group’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-71,200	Closed	-$453K	–	229
2020 Q1	$453K	Sell	71,200 -1,700	-2%	-$13.6K	0.01%	165
2019 Q4	$760K	Buy	+72,900	New	+$530K	0.01%	154
2018 Q3	–	Sell	-17,250	Closed	-$784K	–	145
2018 Q2	$784K	Sell	17,250 -500	-3%	-$24.3K	0.07%	124
2018 Q1	$937K	Sell	17,750 -250	-1%	-$14.6K	0.09%	107
2017 Q4	$1.22M	Sell	18,000 -500	-3%	-$35K	0.13%	104
2017 Q3	$1.52M	Hold	18,500	–	–	0.16%	93
2017 Q2	$1.73M	Hold	18,500	–	–	0.2%	85
2017 Q1	$1.18M	Sell	18,500 -1,500	-8%	-$91.2K	0.16%	96
2016 Q4	$888K	Sell	20,000 -23,000	-53%	-$810K	0.18%	92
2016 Q3	$1.55M	Buy	+43,000	New	+$923K	0.28%	83
2016 Q2	–	Sell	-52,500	Closed	-$1.01M	–	134
2016 Q1	$1.01M	Buy	+52,500	New	+$1.11M	0.18%	96

Other funds holding CLVS

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Candriam SCA Strassen, Luxembourg, Luxembourg $19.3B AUM 39.18% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return